In stage I and II ovarian cancer patients with a high CTCF mRNA expression also displayed a worse OS compared with counterparts with low CTCF mRNA expression (HR = 1.96, 95% CI = 1.02–3.78, p = 0.039, not shown). This evidence concerns the gene CTCF and ovarian carcinoma.